IP Library Granted Patent US 9,636,320
Granted Patent B2
US 9,636,320 · App. 14/867,585 · Granted May 2, 2017

Method for treating skin cancer

Inventor: Michael E. Silver (Holland, MI)
Assignee: The William M. Yarbrough Foundation
A61K31/26A61K9/0014A61K31/16A61K31/198C07C331/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,320
App. No.
14/867,585
Granted
May 2, 2017
Kind
B2
Abstract

A method for treating skin cancer including the steps of applying an isothiocyanate functional surfactant to an area affected by skin cancer, wherein the isothiocyanate functional surfactant comprises at least one isothiocyanate functional group associated with an aliphatic and/or aromatic carbon atom of the isothiocyanate functional surfactant.

Claims (9)

1. A method for treating skin cancer, comprising the step(s) of:

applying a lysine derivative to an area affected by skin cancer, wherein the lysine derivative comprises an α-nitrogen and a ε-nitrogen, and wherein an alkyl and/or alkanoyl substituent comprising at least approximately 8 carbon atoms is associated with the α-nitrogen, and further wherein at least one isothiocyanate functional group is associated with the ε-nitrogen.

2. The method for treating skin cancer, according to claim 1 , wherein the skin cancer is selected from one of the groups comprising basal cell carcinoma, squamous cell carcinoma, melanoma, and merkel cell carcinoma.

3. A method for treating skin cancer, comprising the step(s) of:

applying a lysine derivative to an area affected by skin cancer, wherein the lysine derivative includes an α-nitrogen and a ε-nitrogen, and wherein an alkyl and/or alkanoyl substituent comprising at least 8 carbon atoms is associated with the α-nitrogen, and further wherein at least one isothiocyanate functional group is associated with the ε-nitrogen.

4. The method for treating skin cancer, according to claim 3 , wherein the skin cancer is selected from one of the groups comprising basal cell carcinoma, squamous cell carcinoma, melanoma, and merkel cell carcinoma.

5. A method for treating skin cancer, comprising the step(s) of:

applying a lysine derivative to an area affected by skin cancer, wherein the lysine derivative comprises an α-nitrogen and a ε-nitrogen, and wherein an alkyl substituent comprising at least 8 carbon atoms is associated with the α-nitrogen, and further wherein at least one isothiocyanate functional group is associated with the ε-nitrogen.

6. The method for treating skin cancer, according to claim 5 , wherein the skin cancer is selected from one of the groups comprising basal cell carcinoma, squamous cell carcinoma, melanoma, and merkel cell carcinoma.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2017
From: SILVER, MICHAEL E.
To: THE WILLIAM M YARBROUGH FOUNDATION
Reel/Frame 041461/0537 →
Continuity (4)
Continuation 14519510 · Oct 21, 2014
Continuation 13952236 · Jul 26, 2013
Provisional Application 61676093 · Jul 26, 2012
Related Publication 20160015674A1 · Jan 21, 2016